findmyKOL

Thomas Lad, MD

Basic profile

Cook County Health and Hospitals System

ORCIDNone on fileNPI↗
✓ Full record
RegionChicago, IL · MidwestSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH funding1990–2023Why? →

Thomas Lad is an Oncology physician affiliated with Cook County Health and Hospitals System. OpenAlex indexes 125 publications with 3,226 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
125publications

Distinct works indexed by OpenAlex.

3,226citations

Total citations across indexed works.

26h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 1990–2023

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1901 W Harrison St
Chicago, IL 606123714

Telephone

312-864-6000

Provider last certified this registry record 26 Apr 2021.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    41.8%
    Thalidomide Analog25.3%
    Revlimid52%Lenalidomide38%Pomalyst10%
    Part D<11 patients
    Kinase inhibitor10.8%
    Tagrisso53%Ibrance47%
    Part D<11 patients

    + 1 more class in this area

  • Respiratory

    14.4%
    Opioid Agonist11.3%
    Hydrocodone-Acetaminophen100%
    Part D≥15 patients
    beta2-Adrenergic Agonist3%
    Ventolin Hfa100%
    Part D<11 patients
  • Cardiovascular

    14.2%
    Calcium channel blocker3.6%
    Amlodipine Besylate100%
    Part D<11 patients
    ACE inhibitor2.8%
    Enalapril Maleate100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 1990–2023 per NIH RePORTER. The latest:

All 30 award records: search, sort and filter.Explore →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”